Aksam Limited

POWER SEARCH PRICING

SOLUTIONS

aksam limited Company Information

Live

MatureSmallRapid

Company Number

03258511

Website

http://dudley.gov.uk

Registered Address

14 south lodge avenue, mitcham, surrey, CR4 1LU

Industry

Dispensing chemist in specialised stores

Telephone

02087646107

Next Accounts Due

December 2024

Group Structure

View All

Directors

Nishma Patel4 Years

View All

Shareholders

kandelia pharma limited 100%

aksam limited Estimated Valuation

£1.6m

Pomanda estimates the enterprise value of AKSAM LIMITED at £1.6m based on Net Assets of £652.2k and 2.48x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Aksam Limited is a live company located in surrey, CR4 1LU with a Companies House number of 03258511. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in October 1996, it's largest shareholder is kandelia pharma limited with a 100% stake. Aksam Limited is a mature, small sized company, Pomanda has estimated its turnover at £2.3m with rapid growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Aksam Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 5 areas for improvement. Company Health Check FAQs

Health Rating3out of 5

2 Strong

5 Regular

5 Weak

Size

annual sales of £2.3m, make it smaller than the average company (£11.5m)

Growth

3 year (CAGR) sales growth of 39%, show it is growing at a faster rate (5.3%)

EXPORT

Aksam Limited's latest turnover from March 2023 is estimated at £2.3 million and the company has net assets of £652.2 thousand. According to their latest financial statements, Aksam Limited has 16 employees and maintains cash reserves of £195.1 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Turnover	2,260,751	1,092,535	1,369,374	844,815	962,175	1,042,552	1,008,002	1,120,694	1,353,101	2,867,821	979,959	1,036,223	816,763	738,790
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	1,542,435	741,189	951,334	598,233	681,246	724,094	692,201	775,549	944,948	1,986,539	682,167	733,717	574,557	514,381
Gross Profit	718,316	351,346	418,040	246,581	280,928	318,459	315,802	345,145	408,153	881,281	297,791	302,506	242,206	224,409
Admin Expenses	726,799	264,283	362,720	281,022	332,998	477,117	296,875	284,773	237,645	895,614	136,681	823,187	179,306	-1,177,885
Operating Profit	-8,483	87,063	55,320	-34,441	-52,070	-158,658	18,927	60,372	170,508	-14,333	161,110	-520,681	62,900	1,402,294
Interest Payable	88,857	0	0	244	270	0	0	0	0	0	0	0	0	0
Interest Receivable	10,306	1,459	234	480	5,060	3,345	1,677	3,627	2,302	1,984	2,247	3,447	5,125	2,519
Pre-Tax Profit	-87,035	88,522	55,553	-34,206	-47,281	-155,313	20,604	63,999	172,810	-12,349	163,357	-517,234	68,025	1,404,813
Tax	0	-16,819	-10,555	0	0	0	-4,121	-12,800	-36,290	0	-39,206	0	-19,047	-393,347
Profit After Tax	-87,035	71,703	44,998	-34,206	-47,281	-155,313	16,483	51,199	136,520	-12,349	124,151	-517,234	48,978	1,011,465
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	-87,035	71,703	44,998	-34,206	-47,281	-155,313	16,483	51,199	136,520	-12,349	124,151	-517,234	48,978	1,011,465
Employee Costs	351,794	143,893	155,022	189,279	203,459	219,015	212,470	208,718	207,161	430,715	135,193	134,601	118,427	100,605
Number Of Employees	16	7	8	10	11	12	12	12	12	25	8	8	7	6
EBITDA*	-5,386	89,643	57,368	-34,441	-50,329	-156,336	22,022	62,699	173,574	-11,823	163,660	-517,282	66,860	1,406,406

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Tangible Assets	20,065	29,282	7,572	4,432	5,224	6,965	9,287	6,980	9,198	7,530	7,650	10,198	11,878	12,337
Intangible Assets	1,823,034	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments & Other	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	1,843,099	29,282	7,572	4,432	5,224	6,965	9,287	6,980	9,198	7,530	7,650	10,198	11,878	12,337
Stock & work in progress	139,190	48,760	49,730	57,105	56,405	55,949	55,207	55,352	55,020	54,213	54,117	54,451	53,847	52,900
Trade Debtors	306,267	162,911	280,170	108,873	144,066	168,033	169,802	183,976	217,362	582,176	193,228	239,811	125,652	110,078
Group Debtors	434,500	611,500	553,500	245,000	0	0	0	0	0	0	0	0	0	0
Misc Debtors	59,304	29,865	20,857	35,328	0	25,375	205,437	37,719	0	0	0	0	0	0
Cash	195,055	289,914	99,128	367,990	591,470	757,735	580,370	760,980	689,737	230,922	562,734	336,071	1,042,554	1,007,534
misc current assets	0	0	0	0	0	0	0	0	12,879	0	0	0	0	0
total current assets	1,134,316	1,142,950	1,003,385	814,296	820,929	1,007,092	1,010,816	1,038,027	974,998	867,311	810,079	630,333	1,222,053	1,170,512
total assets	2,977,415	1,172,232	1,010,957	818,728	826,153	1,014,057	1,020,103	1,045,007	984,196	874,841	817,729	640,531	1,233,931	1,182,849
Bank overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	346,321	181,639	243,196	169,406	130,677	126,955	127,341	149,170	190,860	219,048	149,744	96,408	173,097	170,802
Group/Directors Accounts	6,192	117,066	59,066	0	0	85,646	0	13,674	0	0	0	0	0	0
other short term finances	0	0	0	0	8,014	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	235,110	126,993	39,940	26,204	0	96,486	32,046	38,491	0	0	0	0	0	0
total current liabilities	587,623	425,698	342,202	195,610	168,731	309,087	159,387	201,335	190,860	219,048	149,744	96,408	173,097	170,802
loans	1,733,801	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	541	0	0	0	0	0
other liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0
provisions	3,812	7,320	1,244	605	0	970	1,403	842	1,164	682	525	814	389	580
total long term liabilities	1,737,613	7,320	1,244	605	703	970	1,403	842	1,705	682	525	814	389	580
total liabilities	2,325,236	433,018	343,446	196,215	169,434	310,057	160,790	202,177	192,565	219,730	150,269	97,222	173,486	171,382
net assets	652,179	739,214	667,511	622,513	656,719	704,000	859,313	842,830	791,631	655,111	667,460	543,309	1,060,445	1,011,467
total shareholders funds	652,179	739,214	667,511	622,513	656,719	704,000	859,313	842,830	791,631	655,111	667,460	543,309	1,060,445	1,011,467

	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Operating Activities
Operating Profit	-8,483	87,063	55,320	-34,441	-52,070	-158,658	18,927	60,372	170,508	-14,333	161,110	-520,681	62,900	1,402,294
Depreciation	3,097	2,580	2,048	0	1,741	2,322	3,095	2,327	3,066	2,510	2,550	3,399	3,960	4,112
Amortisation	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Tax	0	-16,819	-10,555	0	0	0	-4,121	-12,800	-36,290	0	-39,206	0	-19,047	-393,347
Stock	90,430	-970	-7,375	700	456	742	-145	332	807	96	-334	604	947	52,900
Debtors	-4,205	-50,251	465,326	245,135	-49,342	-181,831	153,544	4,333	-364,814	388,948	-46,583	114,159	15,574	110,078
Creditors	164,682	-61,557	73,790	38,729	3,722	-386	-21,829	-41,690	-28,188	69,304	53,336	-76,689	2,295	170,802
Accruals and Deferred Income	108,117	87,053	13,736	26,204	-96,486	64,440	-6,445	37,950	541	0	0	0	0	0
Deferred Taxes & Provisions	-3,508	6,076	639	605	-970	-433	561	-322	482	157	-289	425	-191	580
Cash flow from operations	177,680	155,617	-322,973	-214,738	-95,177	88,374	-163,211	41,172	474,126	-331,406	224,418	-708,309	33,396	1,021,463
Investing Activities
capital expenditure	-1,816,914	-24,290	-5,188	792	0	0	-5,402	-109	-4,734	-2,390	-2	-1,719	-3,501	-16,449
Change in Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash flow from investments	-1,816,914	-24,290	-5,188	792	0	0	-5,402	-109	-4,734	-2,390	-2	-1,719	-3,501	-16,449
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	-110,874	58,000	59,066	0	-85,646	85,646	-13,674	13,674	0	0	0	0	0	0
Other Short Term Loans	0	0	0	-8,014	8,014	0	0	0	0	0	0	0	0	0
Long term loans	1,733,801	0	0	0	0	0	0	0	0	0	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0
share issue	0	0	0	0	0	0	0	0	0	0	0	98	0	2
interest	-78,551	1,459	234	236	4,790	3,345	1,677	3,627	2,302	1,984	2,247	3,447	5,125	2,519
cash flow from financing	1,544,376	59,459	59,300	-7,778	-72,842	88,991	-11,997	17,301	2,302	1,984	2,247	3,545	5,125	2,521
cash and cash equivalents
cash	-94,859	190,786	-268,862	-223,480	-166,265	177,365	-180,610	71,243	458,815	-331,812	226,663	-706,483	35,020	1,007,534
overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0
change in cash	-94,859	190,786	-268,862	-223,480	-166,265	177,365	-180,610	71,243	458,815	-331,812	226,663	-706,483	35,020	1,007,534

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for aksam limited. Get real-time insights into aksam limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for aksam limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in CR4 area or any other competitors across 12 key performance metrics.

AKSAM LIMITED group structure

Aksam Limited has 1 subsidiary company.

Ultimate parent company

KANDELIA PHARMA LIMITED

11922541

1 parent

AKSAM LIMITED

03258511

1 subsidiary

AKASI PHARMA LIMITED

14312808

AKSAM LIMITED Shareholders

kandelia pharma limited

100%

Aksam Limited currently has 3 directors. The longest serving directors include Ms Nishma Patel (Nov 2019) and Ms Nishma Patel (Nov 2019).

officer	country	age	start	end	role
Ms Nishma Patel	England	46 years	Nov 2019	-	Director
Ms Nishma Patel	England	46 years	Nov 2019	-	Director
Mr Amit Kandelia	England	44 years	Nov 2019	-	Director

P&L

March 2023

turnover

2.3m

+107%

operating profit

-8.5k

gross margin

31.8%

-1.2%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2023

net assets

652.2k

-0.12%

total assets

+1.54%

cash

195.1k

-0.33%

net assets

Total assets minus all liabilities

Similar Companies

worthcare limited

3.5

capsaris (uk) limited

singlewell pharmacy limited

svr chemist limited

2.5

easyrush limited

company number

03258511

Type

Private limited with Share Capital

industry

47730 - Dispensing chemist in specialised stores

incorporation date

October 1996

ultimate parent company

KANDELIA PHARMA LIMITED

previous names

gtt no 17 limited (February 1997)

address

14 south lodge avenue, mitcham, surrey, CR4 1LU

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 6 charges/mortgages relating to aksam limited. Currently there are 6 open charges and 0 have been satisfied in the past.

aksam limited Company Information

aksam limited Estimated Valuation

aksam limited Estimated Valuation

aksam limited Estimated Valuation

Aksam Limited Overview

Aksam Limited Health Check

AKSAM LIMITED financials

aksam limited Credit Report and Business Information

Aksam Limited Competitor Analysis

aksam limited Ownership

aksam limited directors

aksam limited company details

aksam limited Charges & Mortgages

aksam limited Companies House Filings - See Documents